Detalhe da pesquisa
1.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 18(7): 929-945, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600210
2.
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.
Value Health
; 20(10): 1311-1318, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241890
3.
Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.
Histopathology
; 67(3): 279-93, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25585651
4.
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.
NPJ Breast Cancer
; 7(1): 90, 2021 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34238931
5.
Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.
PLoS One
; 15(9): e0238593, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881987
6.
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.
J Clin Oncol
; 38(5): 423-433, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841354
7.
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Health Technol Assess
; 23(30): 1-328, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31264581
8.
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation.
J Clin Epidemiol
; 106: 108-120, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339938
9.
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
J Clin Oncol
; 37(3): 178-189, 2019 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523750
10.
Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
Trials
; 19(1): 50, 2018 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29351790
11.
OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.
Health Technol Assess
; 20(10): xxiii-xxix, 1-201, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26867046
12.
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.
J Natl Cancer Inst
; 108(9)2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27130929
13.
Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer.
J Natl Cancer Inst
; 104(1): 56-66, 2012 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22138097
14.
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.
Eur J Cancer
; 47(15): 2273-81, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21741829
15.
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.
J Clin Oncol
; 27(12): 1999-2006, 2009 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289619
16.
The application of 2D gel-based proteomics methods to the study of breast cancer.
J Mammary Gland Biol Neoplasia
; 7(4): 385-93, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12882523
17.
Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation.
EMBO J
; 22(16): 4178-89, 2003 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12912916
18.
Cluster analysis of an extensive human breast cancer cell line protein expression map database.
Proteomics
; 2(2): 212-23, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11840567